EMA recommends approval of Pfizer-BioNTech vaccine for children aged 5 to 11.
26 Nov, 2021 | 08:47h | UTCRelated:
RCT: Pfizer vaccine shows 90.7% efficacy for preventing Covid-19 in children 5 to 11 years of age.
What COVID vaccines for young kids could mean for the pandemic.
CDC advisers endorse Pfizer’s Covid-19 vaccine for kids 5-11.
FDA advisory panel recommends Pfizer Covid-19 vaccine be authorized for children ages 5 to 11.
Commentary on Twitter
‼️ EMA recommends approval of BioNTech/Pfizer’s #COVID19vaccine, Comirnaty, for children aged 5 to 11.
In this population, the dose of #Comirnaty will be lower than that used in people aged 12 and above.
Read the full press release: https://t.co/uqqBAklVvl pic.twitter.com/NZQhli4SDl
— EU Medicines Agency (@EMA_News) November 25, 2021